Cargando…
Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus
Allogeneic mesenchymal stem cell (MSC) transplantation has recently become a promising therapy for patients with systemic lupus erythematosus (SLE). MSCs are a kind of multipotent stem cell than can efficiently modulate both innate and adaptive immune responses, yet those from SLE patients themselve...
Autores principales: | Zhu, Yantong, Feng, Xuebing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968462/ https://www.ncbi.nlm.nih.gov/pubmed/29793537 http://dx.doi.org/10.1186/s13287-018-0898-x |
Ejemplares similares
-
Serum IFN‐γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients
por: Wang, Dandan, et al.
Publicado: (2017) -
Association of TNF-α with Impaired Migration Capacity of Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2014) -
Umbilical Cord-Derived Mesenchymal Stem Cells Suppress Autophagy of T Cells in Patients with Systemic Lupus Erythematosus via Transfer of Mitochondria
por: Chen, Jinyun, et al.
Publicado: (2016) -
Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype
por: Ceccarelli, Fulvia, et al.
Publicado: (2015) -
Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus
por: Li, Aifen, et al.
Publicado: (2021)